| (+)-Kavain |
|
|
|
|
|
99.10% |
| L-Ascorbic acid calcium dihydrate |
|
|
|
|
|
99.3% |
| L-Ascorbic acid magnesium |
|
|
|
|
|
|
| (+)-Niguldipine |
|
|
|
|
|
|
| (+)-Niguldipine hydrochloride |
|
|
|
|
|
98.06% |
| (-)-Denudatin B |
|
|
|
|
|
97.88% |
| (-)-Gallopamil |
|
|
|
|
|
|
| (-)-Gallopamil hydrochloride |
|
|
|
|
|
|
| (-)-Niguldipine hydrochloride |
|
|
|
|
|
|
| (-)-Praeruptorin A |
|
|
|
|
|
|
| (-)-α-Eudesmol |
|
|
|
|
|
93.98% |
| (17R,18S)-Epoxyeicosatetraenoic acid |
|
|
|
|
|
93.0% |
| (2-Chlorophenyl)diphenylmethanol |
|
|
|
|
|
99.92% |
| (2R,3R)-Butane-2,3-diol |
|
|
|
|
|
99.69% |
| (2R,3R)-Butane-2,3-diol (Standard) |
|
|
|
|
|
98.36% |
| (2R,3R)-Diltiazem hydrochloride |
|
|
|
|
|
|
| (2R/S)-6-PNG |
|
|
|
|
|
99.96% |
| (R)-Carvedilol |
|
|
|
|
|
98.78% |
| (R)-Carvedilol-d4 |
|
|
|
|
|
|
| (R)-(+)-Bay-K-8644 |
|
|
|
|
|
99.36% |
| (R)-(-)-Felodipine-d5 |
|
|
|
|
|
|
| (R)-Amlodipine |
|
|
|
|
|
99.45% |
| (R)-Amlodipine-d4 |
|
|
|
|
|
99.83% |
| (R)-Azelnidipine |
|
|
|
|
|
|
| (R)-IDHP |
|
|
|
|
|
|
| (R)-Lercanidipine |
|
|
|
|
|
|
| (R)-Nicardipine |
|
|
|
|
|
99.73% |
| (R)-Niguldipine |
|
|
|
|
|
|
| (R)-Nimodipine |
|
|
|
|
|
99.87% |
| (R)-TTA-P2 |
|
|
|
|
|
99.95% |
| (R)-Verapamil |
|
|
|
|
|
98.97% |
| (R)-Lercanidipine hydrochloride |
|
|
|
|
|
98.87% |
| (R)-Lercanidipine-d3 hydrochloride |
|
|
|
|
|
99.94% |
| (Rac)-Benidipine-d7 |
|
|
|
|
|
|
| (Rac)-Ibrutinib alkyne |
|
|
|
|
|
99.35% |
| (Rac)-MEM 1003 |
|
|
|
|
|
99.64% |
| (Rac)-NNC 55-0396 |
|
|
|
|
|
96.20% |
| (Rac)-PD0299685 |
|
|
|
|
|
|
| (Rac)-TTA-P2 |
|
|
|
|
|
98.69% |
| (rel)-Mirogabalin |
|
|
|
|
|
|
| (S)-(-)-Bay-K-8644 |
|
|
|
|
|
99.22% |
| (S)-(-)-Felodipine |
|
|
|
|
|
|
| (S)-2-Amino-2-(p-tolyl)acetic acid |
|
|
|
|
|
|
| (S)-Albuterol hydrochloride |
|
|
|
|
|
|
| (S)-Azelnidipine |
|
|
|
|
|
|
| (S)-IDOR-1117-2520 |
|
|
|
|
|
99.47% |
| (S)-Lercanidipine hydrochloride |
|
|
|
|
|
|
| (S)-Nicardipine |
|
|
|
|
|
99.73% |
| (S)-Nimodipine |
|
|
|
|
|
99.92% |
| (S)-TROX-1 |
|
|
|
|
|
99.52% |
| (S)-Verapamil hydrochloride |
|
|
|
|
|
99.02% |
| (S)-Verapamil-d7 hydrochloride |
|
|
|
|
|
|
| (S)-Lercanidipine |
|
|
|
|
|
|
| (S)-Albuterol |
|
|
|
|
|
|
| (S)-Lercanidipine-d3 hydrochloride |
|
|
|
|
|
|
| (S)-Verapamil-d6 hydrochloride |
|
|
|
|
|
|
| (±)-Praeruptorin A |
|
|
|
|
|
99.94% |
| DHP-050 |
|
|
|
|
|
98.58% |
| 1-Myristyl-2-hydroxy-sn-glycero-3-PA |
|
|
|
|
|
|
| 14-Deoxyandrographolide |
|
|
|
|
|
99.94% |
| 15-Methoxypinusolidic acid |
|
|
|
|
|
|
| 2',3'-Cyclic NADP disodium |
|
|
|
|
|
|
| 2'-O-Methyl Uridine-d3 |
|
|
|
|
|
|
| 2,5-Di-tert-butylhydroquinone |
|
|
|
|
|
99.73% |
| 2,6-Dibromophenol |
|
|
|
|
|
99.76% |
| 2-(tert-Butyl)-4,6-dimethylphenol |
|
|
|
|
|
|
| 2-Aminoethyl diphenylborinate |
|
|
|
|
|
98.86% |
| 2-Chloro-ATP sodium |
|
|
|
|
|
98.41% |
| 20:4 Lyso PI |
|
|
|
|
|
|
| 24-Oxo-25-hydroxyvitamin D3 |
|
|
|
|
|
|
| 25,26-Dihydroxyvitamin D3 |
|
|
|
|
|
95.47% |
| 3,5,7,3′,4′-Pentamethoxyflavone |
|
|
|
|
|
99.69% |
| 4,4'-Methylenebis(2,6-di-tert-butylphenol) |
|
|
|
|
|
99.83% |
| 4-Bromo A23187 |
|
|
|
|
|
95.46% |
| 5,6-DiHETE |
|
|
|
|
|
97.00% |
| 5,6-Epoxyeicosatrienoic acid |
|
|
|
|
|
99.07% |
| 5-Hydroxyindole |
|
|
|
|
|
99.94% |
| 5-Hydroxyindole (Standard) |
|
|
|
|
|
|
| 7,4'-Dimethoxy-3-hydroxyflavone |
|
|
|
|
|
|
| 8-[2-(3-Methylbutroxy)-3-hydroxy-3-methylbutoxy]psoralen |
|
|
|
|
|
|
| 8-Br-7-CH-cADPR |
|
|
|
|
|
|
| 8-Br-7-CH-cADPR disodium |
|
|
|
|
|
|
| 8-Br-NAD+ sodium |
|
|
|
|
|
98.7% |
| 8-Bromo-cGMP sodium |
|
|
|
|
|
99.89% |
| IPrAuCl |
|
|
|
|
|
98.2% |
| [DArg10, DAla20] TLQP-21 |
|
|
|
|
|
|
| A-1048400 |
|
|
|
|
|
|
| A-39355 |
|
|
|
|
|
|
| A-80b |
|
|
|
|
|
|
| ABT-639 |
|
|
|
|
|
99.32% |
| ABT-639 hydrochloride |
|
|
|
|
|
|
| Acetyljujuboside B |
|
|
|
|
|
|
| AChE/BChE-IN-21 |
|
|
|
|
|
|
| ACS-67 |
|
|
|
|
|
|
| Adenophostin A |
|
|
|
|
|
|
| AE0047 Hydrochloride |
|
|
|
|
|
|
| Agelenin |
|
|
|
|
|
|
| AH-1058 |
|
|
|
|
|
|
| AH3960 |
|
|
|
|
|
99.92% |
| AJ-3941 |
|
|
|
|
|
|
| AJG049 |
|
|
|
|
|
|
| AJG049 free base |
|
|
|
|
|
|
| AK-2-38 |
|
|
|
|
|
|
| Aladorian |
|
|
|
|
|
99.31% |
| Aladorian sodium |
|
|
|
|
|
|
| Almorexant |
|
|
|
|
|
99.96% |
| Almorexant hydrochloride |
|
|
|
|
|
99.98% |
| Aminoadipic acid |
|
|
|
|
|
99.94% |
| Amlodipine aspartic acid impurity |
|
|
|
|
|
99.42% |
| Amlodipine mesylate |
|
|
|
|
|
|
| Amlodipine metabolite |
|
|
|
|
|
|
| Amlodipine orotate |
|
|
|
|
|
|
| Ancriviroc |
|
|
|
|
|
|
| Annonacin |
|
|
|
|
|
98.09% |
| ANO61 |
|
|
|
|
|
|
| Anti-Mouse CD3E Antibody (500A2) |
|
|
|
|
|
|
| Antiallergic agent-5 |
|
|
|
|
|
|
| Antiarrhythmic agent-2 |
|
|
|
|
|
|
| Anticonvulsant agent 7 |
|
|
|
|
|
|
| Ap3A |
|
|
|
|
|
|
| Apinocaltamide |
|
|
|
|
|
99.83% |
| Aprindine |
|
|
|
|
|
98.43% |
| Aprindine hydrochloride-d10 |
|
|
|
|
|
|
| Araguspongin B |
|
|
|
|
|
|
| AT1R antagonist 3 |
|
|
|
|
|
|
| AT1R antagonist 4 |
|
|
|
|
|
|
| ATI22-107 |
|
|
|
|
|
|
| AWD 122-60 |
|
|
|
|
|
|
| AZ-DF 265 |
|
|
|
|
|
|
| AZD 2066 |
|
|
|
|
|
99.8% |
| AZD 2066 hydrate |
|
|
|
|
|
|
| AZD-1305 |
|
|
|
|
|
|
| AZD-2066 hydrochloride |
|
|
|
|
|
|
| Azumolene sodium |
|
|
|
|
|
|
| Barbamide |
|
|
|
|
|
|
| Barium chloride |
|
|
|
|
|
99.99% |
| Bastadins-5 |
|
|
|
|
|
|
| Bay K 8644 |
|
|
|
|
|
99.96% |
| Bay Y5959 |
|
|
|
|
|
|
| BBR 2160 |
|
|
|
|
|
|
| BBT |
|
|
|
|
|
99.71% |
| Belfosdil |
|
|
|
|
|
|
| Benidipine |
|
|
|
|
|
|
| BER-5 |
|
|
|
|
|
99.83% |
| BGC-201259 |
|
|
|
|
|
|
| BIM-23197 |
|
|
|
|
|
|
| BL-1021 |
|
|
|
|
|
|
| BMS-188107 |
|
|
|
|
|
|
| BMS-192364 |
|
|
|
|
|
99.01% |
| BMS-195270 |
|
|
|
|
|
97.52% |
| BN 50341 |
|
|
|
|
|
|
| BODIPY FL Thapsigargin |
|
|
|
|
|
|
| Bovine brain Calcineurin |
|
|
|
|
|
|
| Brevetoxin B |
|
|
|
|
|
95.0% |
| BTT-266 |
|
|
|
|
|
98.90% |
| BTT-369 |
|
|
|
|
|
|
| Budiodarone |
|
|
|
|
|
|
| Budiodarone tartrate |
|
|
|
|
|
98.14% |
| Budiodarone-d10 |
|
|
|
|
|
|
| Budiodarone-d10 tartrate |
|
|
|
|
|
|
| Bupivacaine liposome |
|
|
|
|
|
|
| Butenoyl-PAF |
|
|
|
|
|
|
| BX430 |
|
|
|
|
|
99.21% |
| C18 LPA |
|
|
|
|
|
|
| C24-Ceramide (d18:1/24:0) |
|
|
|
|
|
99% |
| Ca2+ -Langerin-IN-1 |
|
|
|
|
|
|
| Ca2+ channel agonist 1 |
|
|
|
|
|
98.87% |
| CAD204520 |
|
|
|
|
|
99.22% |
| CAD204520 dihydrochloride |
|
|
|
|
|
99.26% |
| Calamenene |
|
|
|
|
|
|
| Calcicludine |
|
|
|
|
|
|
| Calciseptine |
|
|
|
|
|
|
| Calciseptine TFA |
|
|
|
|
|
97.55% |
| Calcitonin (chicken) |
|
|
|
|
|
|
| Calcium Channel antagonist 1 |
|
|
|
|
|
|
| Calcium Channel antagonist 2 |
|
|
|
|
|
98.0% |
| Calcium Channel antagonist 3 |
|
|
|
|
|
98.0% |
| Calcium Channel antagonist 4 |
|
|
|
|
|
95.0% |
| Calcium Channel antagonist 5 |
|
|
|
|
|
|
| Calcium Channel antagonist 6 |
|
|
|
|
|
|
| Calcium channel-modulator-1 |
|
|
|
|
|
98.77% |
| Calcium Green-5N AM |
|
|
|
|
|
|
| Calcium influx inducer compound 634 |
|
|
|
|
|
|
| Calenduloside E |
|
|
|
|
|
99.07% |
| Caloxin 1b3 |
|
|
|
|
|
99.81% |
| Caloxin 1C2 |
|
|
|
|
|
99.47% |
| Caloxin 3A1 |
|
|
|
|
|
|
| CALP3 |
|
|
|
|
|
99.55% |
| CALP3 TFA |
|
|
|
|
|
|
| Calpain Inhibitor-2 |
|
|
|
|
|
|
| Candidalysin |
|
|
|
|
|
99.81% |
| Capa-2 |
|
|
|
|
|
|
| Carboxyamidotriazole |
|
|
|
|
|
99.82% |
| Carboxyamidotriazole Orotate |
|
|
|
|
|
99.74% |
| Carboxyatractyloside dipotassium |
|
|
|
|
|
99.57% |
| Catenarin |
|
|
|
|
|
|
| Cav 2.2 blocker 1 |
|
|
|
|
|
98.85% |
| Cav 2.2/3.2 blocker 1 |
|
|
|
|
|
|
| Cav 3.1 blocker 1 |
|
|
|
|
|
|
| Cav 3.2 inhibitor 1 |
|
|
|
|
|
|
| Cav 3.2 inhibitor 2 |
|
|
|
|
|
|
| Cav 3.2 inhibitor 3 |
|
|
|
|
|
|
| Cav 3.2 inhibitor 4 |
|
|
|
|
|
|
| CaV1.3 antagonist-1 |
|
|
|
|
|
98.38% |
| Cavα2δ-IN-1 |
|
|
|
|
|
|
| Cavα2δ1&NET-IN-1 |
|
|
|
|
|
|
| Cavα2δ1&NET-IN-2 |
|
|
|
|
|
|
| Cavα2δ1&NET-IN-3 |
|
|
|
|
|
|
| CBD3063 |
|
|
|
|
|
99.75% |
| Cd1a |
|
|
|
|
|
|
| CDN1163 |
|
|
|
|
|
99.84% |
| Cerebellin |
|
|
|
|
|
|
| Cerebellin TFA |
|
|
|
|
|
95.43% |
| Cerebrocrast |
|
|
|
|
|
|
| CERM11956 |
|
|
|
|
|
|
| Cetiedil citrate |
|
|
|
|
|
|
| CGP 28392 |
|
|
|
|
|
|
| CHF-6366 |
|
|
|
|
|
|
| Chlorocresol |
|
|
|
|
|
99.21% |
| Cholecystokinin-J |
|
|
|
|
|
|
| Chromostatin (bovine) |
|
|
|
|
|
|
| Chrysosplenol C |
|
|
|
|
|
|
| Cicletanine |
|
|
|
|
|
|
| Cimicifugic acid D |
|
|
|
|
|
|
| cis-Ned19 |
|
|
|
|
|
99.25% |
| CK-963 |
|
|
|
|
|
99.23% |
| Clonixin |
|
|
|
|
|
98.88% |
| Clonixin-13C,d3 |
|
|
|
|
|
|
| Clopimozide |
|
|
|
|
|
99.63% |
| Coelenterazine h hydrochloride |
|
|
|
|
|
99.65% |
| COX-2-IN-55 |
|
|
|
|
|
99.20% |
| COX-2/CaV2.2-IN-1 |
|
|
|
|
|
|
| CP-060 |
|
|
|
|
|
|
| CP-288886 |
|
|
|
|
|
|
| CPU-228 |
|
|
|
|
|
|
| Crisugabalin |
|
|
|
|
|
99.88% |
| Cronidipine |
|
|
|
|
|
98.83% |
| CTP-amiodarone |
|
|
|
|
|
|
| CXL 017 |
|
|
|
|
|
|
| CXL-1020 |
|
|
|
|
|
|
| Cyclic ADP-ribose ammonium |
|
|
|
|
|
99.9% |
| Cyclic ADP-ribose diammonium |
|
|
|
|
|
|
| CYD-1-79 |
|
|
|
|
|
|
| D-GsMTx4 |
|
|
|
|
|
99.44% |
| D-GsMTx4 TFA |
|
|
|
|
|
99.89% |
| D-myo-Inositol 1,4,5-trisphosphate hexapotassium salt |
|
|
|
|
|
98% |
| D-myo-Inositol 1,4,5-trisphosphate sodium salt |
|
|
|
|
|
|
| D-myo-Inositol 1,4,5-trisphosphate tripotassium |
|
|
|
|
|
98.00% |
| D-myo-Inositol-1,2,3,5-tetraphosphate tetrasodium |
|
|
|
|
|
|
| D-myo-Inositol-1,2,4,5,6-pentaphosphate sodium salt |
|
|
|
|
|
98.0% |
| D-myo-Inositol-1,2,4,5-tetraphosphate tetrasodium salt |
|
|
|
|
|
98.0% |
| D-myo-Inositol-1,2,6-triphosphate sodium |
|
|
|
|
|
|
| D-myo-Inositol-1,2-diphosphate sodium |
|
|
|
|
|
|
| D-myo-Inositol-1,4,5,6-tetraphosphate sodium |
|
|
|
|
|
|
| D-myo-Inositol-1,4,5-triphosphate trisodium |
|
|
|
|
|
99.8% |
| D-myo-Inositol-2,3,5,6-tetraphosphate tetrasodium |
|
|
|
|
|
|
| D-myo-Inositol-2,4,5-triphosphate sodium salt |
|
|
|
|
|
|
| D-myo-Inositol-3,4,5-triphosphate hexasodium |
|
|
|
|
|
|
| D-myo-Inositol-4-phosphate monoammonium |
|
|
|
|
|
|
| Deltamethrin-d6 |
|
|
|
|
|
|
| DHBP dibromide |
|
|
|
|
|
99.17% |
| DHP-218 |
|
|
|
|
|
|
| Dichlorobenzamil |
|
|
|
|
|
|
| Didrovaltrate |
|
|
|
|
|
92.0% |
| Diltiazem-d6 hydrochloride |
|
|
|
|
|
|
| Diplacone |
|
|
|
|
|
98.38% |
| Diproteverine |
|
|
|
|
|
|
| Diproteverine hydrochloride |
|
|
|
|
|
|
| dl-Tetrandrine |
|
|
|
|
|
|
| DL-Phenylalanine-d5 hydrochloride |
|
|
|
|
|
|
| DL-Phenylalanine-d5 |
|
|
|
|
|
99.95% |
| DMNPE-4 AM-caged-calcium |
|
|
|
|
|
|
| Dotarizine |
|
|
|
|
|
|
| DP-b99 |
|
|
|
|
|
95.0% |
| DPO-1 |
|
|
|
|
|
98.39% |
| DPP8/9-IN-2 |
|
|
|
|
|
|
| Dronedarone-d6 |
|
|
|
|
|
|
| Drotaverine hydrochloride |
|
|
|
|
|
99.65% |
| Drotaverine-d10 hydrochloride |
|
|
|
|
|
|
| EL20 |
|
|
|
|
|
|
| Elgodipine |
|
|
|
|
|
|
| Eloralintide |
|
|
|
|
|
99.97% |
| Eloralintide sodium |
|
|
|
|
|
99.72% |
| Elpetrigine |
|
|
|
|
|
|
| Emopamil |
|
|
|
|
|
|
| Enecadin |
|
|
|
|
|
99.71% |
| Ent-(+)-Verticilide |
|
|
|
|
|
99.91% |
| EO-122 |
|
|
|
|
|
|
| ERG-IN-7 |
|
|
|
|
|
|
| Ethacrynic acid (Standard) |
|
|
|
|
|
98.78% |
| Ethacrynic acid D5 |
|
|
|
|
|
|
| Ethacrynic acid-13C2,d5 |
|
|
|
|
|
|
| Ethaverine hydrochloride |
|
|
|
|
|
99.72% |
| Etripamil |
|
|
|
|
|
98.10% |
| Etripamil hydrochloride |
|
|
|
|
|
|
| Evariquinone |
|
|
|
|
|
|
| F-0401 |
|
|
|
|
|
|
| Falipamil |
|
|
|
|
|
|
| Fantofarone |
|
|
|
|
|
99.91% |
| Farnesyl pyrophosphate |
|
|
|
|
|
|
| Farnesyl pyrophosphate ammonium |
|
|
|
|
|
95.39% |
| Farnesyl pyrophosphate-d2 triammonium |
|
|
|
|
|
95.78% |
| Farnesyl pyrophosphate-d6 |
|
|
|
|
|
|
| Fasedienol |
|
|
|
|
|
99.68% |
| Fasudil dihydrochloride |
|
|
|
|
|
99.98% |
| Fasudil mesylate |
|
|
|
|
|
|
| Ferroptosis/apoptosis inducer-3 |
|
|
|
|
|
|
| FK 584 |
|
|
|
|
|
|
| Flavoxate |
|
|
|
|
|
98.07% |
| Flavoxate-d5 |
|
|
|
|
|
|
| Flordipine |
|
|
|
|
|
|
| Flosatidil |
|
|
|
|
|
|
| Flunarizine |
|
|
|
|
|
99.79% |
| Fluspirilene |
|
|
|
|
|
99.44% |
| Fmoc-leucine |
|
|
|
|
|
99.9% |
| Fostedil |
|
|
|
|
|
|
| FPL 62129 |
|
|
|
|
|
|
| FPL64176 |
|
|
|
|
|
99.86% |
| FPR2 agonist 5 |
|
|
|
|
|
|
| FS-2 |
|
|
|
|
|
|
| Fukinolic acid |
|
|
|
|
|
|
| Fura-2 leakage resistant AM |
|
|
|
|
|
|
| FURNIDIPINE |
|
|
|
|
|
|
| Gallium 8-Hydroxyquinolinate |
|
|
|
|
|
99.86% |
| Gallopamil |
|
|
|
|
|
|
| Gallopamil hydrochloride |
|
|
|
|
|
98.10% |
| GeX-2 |
|
|
|
|
|
|
| GIP (22-51) human |
|
|
|
|
|
|
| Globotriaosylsphingosine |
|
|
|
|
|
99.78% |
| GluN1(356-385) |
|
|
|
|
|
99.95% |
| Glycerophosphoinositol 4,5-diphosphate trisodium |
|
|
|
|
|
|
| GPR40 agonist 8 |
|
|
|
|
|
|
| GSK-7975A |
|
|
|
|
|
99.83% |
| GSK1016790A |
|
|
|
|
|
99.93% |
| GTx1-15 |
|
|
|
|
|
|
| GV-58 |
|
|
|
|
|
99.22% |
| GW7845 |
|
|
|
|
|
|
| GZ4 |
|
|
|
|
|
|
| H052 |
|
|
|
|
|
|
| HA-1004 dihydrochloride |
|
|
|
|
|
|
| HA-1004 hydrochloride |
|
|
|
|
|
|
| Halofuginone hydrochloride |
|
|
|
|
|
|
| Halofuginone lactate |
|
|
|
|
|
98.32% |
| HC-056456 |
|
|
|
|
|
98.0% |
| HCA-6 |
|
|
|
|
|
|
| Hepoxilin A3 methyl ester |
|
|
|
|
|
|
| Hexadecylphosphoserine |
|
|
|
|
|
|
| Hexadecylphosphoserine TFA |
|
|
|
|
|
98.0% |
| Hirudin (54-65) |
|
|
|
|
|
99.20% |
| HKC54 |
|
|
|
|
|
|
| HM12 |
|
|
|
|
|
|
| HNS-32 |
|
|
|
|
|
|
| HUP30 |
|
|
|
|
|
99.68% |
| Huwentoxin I |
|
|
|
|
|
|
| Huwentoxin XVI |
|
|
|
|
|
|
| Huwentoxin XVI TFA |
|
|
|
|
|
|
| IAA65 |
|
|
|
|
|
|
| IAB15 |
|
|
|
|
|
|
| IDO1-IN-19 |
|
|
|
|
|
98.82% |
| IDOR-1117-2520 |
|
|
|
|
|
99.94% |
| Iganidipine dihydrochloride |
|
|
|
|
|
|
| ILS-920 |
|
|
|
|
|
99.26% |
| Imperatoxin A |
|
|
|
|
|
|
| Imperatoxin A TFA |
|
|
|
|
|
98.25% |
| Inositol 1,3-bisphosphate sodium |
|
|
|
|
|
|
| IP3RCYT |
|
|
|
|
|
95.87% |
| IP3RPEP6 |
|
|
|
|
|
98.36% |
| IS4 |
|
|
|
|
|
|
| Istaroxime hydrochloride |
|
|
|
|
|
99.28% |
| ISX-9 |
|
|
|
|
|
99.76% |
| ISX-9 |
|
|
|
|
|
|
| ITH12575 |
|
|
|
|
|
98.84% |
| JNJ-26489112 |
|
|
|
|
|
99.31% |
| JNJ-26990990 |
|
|
|
|
|
|
| JTV-519 |
|
|
|
|
|
98.0% |
| JTV-519 free base |
|
|
|
|
|
|
| JTV-519 fumarate |
|
|
|
|
|
|
| JTV-519 hemifumarate |
|
|
|
|
|
99.74% |
| JW480 |
|
|
|
|
|
99.82% |
| JW480 (Standard) |
|
|
|
|
|
|
| JWU-A021 |
|
|
|
|
|
|
| Kadethrin |
|
|
|
|
|
|
| KARI 101 |
|
|
|
|
|
|
| KB130015 |
|
|
|
|
|
98.45% |
| KCa1.1 channel activator-1 |
|
|
|
|
|
|
| KS0365 |
|
|
|
|
|
|
| KT 2-230 |
|
|
|
|
|
|
| KT-362 |
|
|
|
|
|
|
| KT-362 free acid |
|
|
|
|
|
|
| KTt-45 |
|
|
|
|
|
|
| Kurtoxin |
|
|
|
|
|
|
| L-Ascorbic acid |
|
|
|
|
|
|
| L-Ascorbic acid (GMP Like) |
|
|
|
|
|
99.88% |
| L-Phenylalanine-d1 |
|
|
|
|
|
|
| L-Ascorbic acid-13C-1 |
|
|
|
|
|
99.90% |
| L-Ascorbic acid-13C-4 |
|
|
|
|
|
|
| L-Ascorbic acid-13C-2 |
|
|
|
|
|
95.0% |
| L-Ascorbic acid-13C-3 |
|
|
|
|
|
|
| L-Ascorbic acid-13C6-1 |
|
|
|
|
|
99.37% |
| L-Ascorbic acid-13C6 |
|
|
|
|
|
99.9% |
| L-Ascorbic acid-13C |
|
|
|
|
|
99.90% |
| L-Ascorbic acid-d2 |
|
|
|
|
|
99.90% |
| L-Ascorbic acid |
|
|
|
|
|
99.96% |
| L-Ascorbic acid sodium salt |
|
|
|
|
|
99.01% |
| L-Phenylalanine-13C |
|
|
|
|
|
99.66% |
| L-Phenylalanine-13C9 |
|
|
|
|
|
98.09% |
| L-Phenylalanine-13C9,15N |
|
|
|
|
|
99.42% |
| L-Phenylalanine-15N |
|
|
|
|
|
98.38% |
| L-Phenylalanine-15N,d8 |
|
|
|
|
|
99.90% |
| L-Phenylalanine-3-13C |
|
|
|
|
|
99.56% |
| L-Phenylalanine-d |
|
|
|
|
|
|
| L-Phenylalanine-d2 |
|
|
|
|
|
99.00% |
| L-Phenylalanine-d7 |
|
|
|
|
|
99.90% |
| L-Phenylalanine-d8 |
|
|
|
|
|
99.99% |
| L-Phenylalanine-13C-1 |
|
|
|
|
|
|
| L-Phenylalanine-13C6 |
|
|
|
|
|
99.87% |
| L-Phenylalanine-13C9,15N,d8 |
|
|
|
|
|
|
| L-Phenylalanine-d5 |
|
|
|
|
|
99.90% |
| L-Phenylalanine |
|
|
|
|
|
99.98% |
| Landiolol |
|
|
|
|
|
|
| Landiolol-d8 |
|
|
|
|
|
|
| Leualacin |
|
|
|
|
|
|
| Leukotriene E4-d5 |
|
|
|
|
|
98.5% |
| Levamlodipine gentisate |
|
|
|
|
|
|
| Levamlodipine hydrobromide |
|
|
|
|
|
|
| Levamlodipine hydrochloride |
|
|
|
|
|
|
| Levemopamil hydrochloride |
|
|
|
|
|
|
| Levobunolol |
|
|
|
|
|
|
| Levomepromazine hydrochloride |
|
|
|
|
|
|
| Levomepromazine-d6 hydrochloride |
|
|
|
|
|
|
| Lidoflazine |
|
|
|
|
|
98.1% |
| Linoleamide |
|
|
|
|
|
99.4% |
| Lnd 796 |
|
|
|
|
|
|
| LOE 908 hydrochloride |
|
|
|
|
|
|
| Lomerizine-d4 |
|
|
|
|
|
|
| LPLRF-NH2 |
|
|
|
|
|
|
| LQFM020 |
|
|
|
|
|
|
| Lubeluzole |
|
|
|
|
|
|
| Lubeluzole dihydrochloride |
|
|
|
|
|
99.00% |
| LY393615 |
|
|
|
|
|
|
| LY393615 free base |
|
|
|
|
|
|
| Lyso-PAF C-18-d4 |
|
|
|
|
|
|
| m-Nisoldipine |
|
|
|
|
|
|
| MAGL-IN-13 |
|
|
|
|
|
|
| Mast cell degranulating peptide (28-49) |
|
|
|
|
|
|
| Maurocalcine |
|
|
|
|
|
|
| Maurocalcine TFA |
|
|
|
|
|
95.09% |
| MCaE12A |
|
|
|
|
|
|
| MCI-176 |
|
|
|
|
|
|
| McN5691 |
|
|
|
|
|
|
| MCU-i11 |
|
|
|
|
|
98.05% |
| Menthol-d2 |
|
|
|
|
|
|
| Menthol-d4 |
|
|
|
|
|
|
| Methsuximide |
|
|
|
|
|
99.68% |
| Methyl homoveratrate |
|
|
|
|
|
98.21% |
| Mibefradil dihydrochloride hydrate |
|
|
|
|
|
|
| Migrastatin |
|
|
|
|
|
|
| Minocycline |
|
|
|
|
|
98.59% |
| Minocycline-d6 |
|
|
|
|
|
|
| Minocycline-d6 hydrochloride |
|
|
|
|
|
|
| Minocycline-d6 sulfate |
|
|
|
|
|
95.21% |
| Mioflazine (di(hydrochloride) hydrate) |
|
|
|
|
|
|
| Mioflazine dihydrochloride |
|
|
|
|
|
|
| Mirogabalin |
|
|
|
|
|
99.22% |
| Mirogabalin besylate |
|
|
|
|
|
99.57% |
| Mirogabalin-d4 |
|
|
|
|
|
|
| Mito-TEMPO |
|
|
|
|
|
99.19% |
| MitoTEMPO hydrate |
|
|
|
|
|
98.03% |
| MK-7622 |
|
|
|
|
|
99.80% |
| ML218 |
|
|
|
|
|
99.49% |
| ML218 hydrochloride |
|
|
|
|
|
|
| ML218-d9 |
|
|
|
|
|
|
| MMK1 |
|
|
|
|
|
99.71% |
| MMK1 TFA |
|
|
|
|
|
|
| MN-05 |
|
|
|
|
|
|
| Monatepil maleate |
|
|
|
|
|
|
| MONIRO-1 |
|
|
|
|
|
99.18% |
| MP-010 |
|
|
|
|
|
|
| MRS 1523 |
|
|
|
|
|
99.97% |
| MRS1845 |
|
|
|
|
|
99.46% |
| MRS2690 |
|
|
|
|
|
|
| MRS2690 disodium |
|
|
|
|
|
|
| Multi-kinase-IN-10 |
|
|
|
|
|
|
| Multi-target kinase-IN-6 |
|
|
|
|
|
|
| Multitarget AD-IN-4 |
|
|
|
|
|
|
| Myoregulin |
|
|
|
|
|
|
| Myoregulin TFA |
|
|
|
|
|
|
| Myr-TAT-CBD3 |
|
|
|
|
|
|
| N-Arachidonyldopamine |
|
|
|
|
|
98.36% |
| N-Benzylethylenediamine |
|
|
|
|
|
99.79% |
| N-Desalkylflurazepam |
|
|
|
|
|
99.95% |
| N-Feruloylserotonin |
|
|
|
|
|
99.93% |
| N-Salicyloyltryptamine |
|
|
|
|
|
96.37% |
| N-type calcium channel blocker-1 |
|
|
|
|
|
|
| N106 |
|
|
|
|
|
99.58% |
| NAADP receptor modulator-1 |
|
|
|
|
|
|
| NAADP tetrasodium |
|
|
|
|
|
99.1% |
| Naltiazem |
|
|
|
|
|
|
| Naltiazem hydrochloride |
|
|
|
|
|
|
| Nav1.2-IN-2 |
|
|
|
|
|
99.82% |
| Nebracetam |
|
|
|
|
|
|
| Nebracetam hydrochloride |
|
|
|
|
|
99.0% |
| NecroX-5 |
|
|
|
|
|
98.02% |
| NecroX-5 free base |
|
|
|
|
|
|
| Ned 19 |
|
|
|
|
|
99.92% |
| Ned-K |
|
|
|
|
|
99.35% |
| Nelutroctiv |
|
|
|
|
|
99.57% |
| Nemadipine B |
|
|
|
|
|
95.90% |
| Nemadipine-A |
|
|
|
|
|
98.87% |
| Nesiritide acetate |
|
|
|
|
|
|
| Nexopamil |
|
|
|
|
|
|
| Niguldipine |
|
|
|
|
|
|
| Niguldipine monohydrochloride |
|
|
|
|
|
|
| Niludipine |
|
|
|
|
|
|
| NIP 142 |
|
|
|
|
|
|
| NMDAR blocker 1 |
|
|
|
|
|
|
| NNC 55-0396 |
|
|
|
|
|
98.43% |
| NNC 55-0396 free base |
|
|
|
|
|
|
| Norfluoxetine |
|
|
|
|
|
98.71% |
| Norfluoxetine hydrochloride |
|
|
|
|
|
99.58% |
| Norfluoxetine oxalate |
|
|
|
|
|
|
| Norfluoxetine-d5 |
|
|
|
|
|
|
| Norfluoxetine-d5 hydrochloride |
|
|
|
|
|
99.30% |
| Norverapamil-d7 |
|
|
|
|
|
|
| Norverapamil-d7 hydrochloride |
|
|
|
|
|
98.77% |
| Nothofagin |
|
|
|
|
|
|
| NP-252 |
|
|
|
|
|
|
| NP118809 |
|
|
|
|
|
98.73% |
| NS-638 |
|
|
|
|
|
99.84% |
| NSC156529 |
|
|
|
|
|
|
| o-3M3FBS |
|
|
|
|
|
99.79% |
| O-Desmethyl carvedilol-d5 |
|
|
|
|
|
|
| O-Desmethylcarvedilol |
|
|
|
|
|
97.4% |
| ONO-2921 |
|
|
|
|
|
|
| Onychocin B |
|
|
|
|
|
|
| Ophiobolin A |
|
|
|
|
|
98.86% |
| Org 30029 hydrochloride |
|
|
|
|
|
|
| Ouabain |
|
|
|
|
|
|
| Oxodipine |
|
|
|
|
|
|
| PACAP (1-38), human, ovine, rat |
|
|
|
|
|
99.99% |
| PACAP (1-38), human, ovine, rat TFA |
|
|
|
|
|
|
| Palmitoylcarnitine chloride |
|
|
|
|
|
98.0% |
| Palonidipine hydrochloride |
|
|
|
|
|
|
| PAM-2 |
|
|
|
|
|
|
| PAMP-12 (unmodified) |
|
|
|
|
|
99.40% |
| PAMP-12 (unmodified) TFA |
|
|
|
|
|
|
| PAQ |
|
|
|
|
|
|
| Parametadione |
|
|
|
|
|
|
| PD 122860 |
|
|
|
|
|
|
| PD 175069 |
|
|
|
|
|
|
| PD-0299685 |
|
|
|
|
|
|
| PD-151307 |
|
|
|
|
|
|
| PD-217014 |
|
|
|
|
|
|
| PD-217014-methyl ester |
|
|
|
|
|
|
| PD0176078 |
|
|
|
|
|
99.80% |
| PD173212 |
|
|
|
|
|
98.88% |
| PDDHV |
|
|
|
|
|
|
| PDE1-IN-4 |
|
|
|
|
|
|
| Perisulfakinin |
|
|
|
|
|
|
| PeS-9 |
|
|
|
|
|
|
| Phenchlobenpyrrone |
|
|
|
|
|
|
| Piprofurol |
|
|
|
|
|
|
| Plantainoside D |
|
|
|
|
|
99.15% |
| PLTX-II |
|
|
|
|
|
|
| PptT-IN-4 |
|
|
|
|
|
|
| PPZ2 |
|
|
|
|
|
99.92% |
| Pramiverine hydrochloride |
|
|
|
|
|
|
| Pranidipine |
|
|
|
|
|
99.52% |
| Pregabalin diacid |
|
|
|
|
|
98.47% |
| Proadrenomedullin (1-20), human |
|
|
|
|
|
99.53% |
| ProTx-I |
|
|
|
|
|
95.15% |
| Quadrol |
|
|
|
|
|
99.96% |
| Quinpirole |
|
|
|
|
|
98.95% |
| R 56865 |
|
|
|
|
|
|
| RAC 109 |
|
|
|
|
|
|
| RCC-36 hydrochloride |
|
|
|
|
|
|
| Rec 15/2615 |
|
|
|
|
|
|
| Recoflavone |
|
|
|
|
|
98.0% |
| rel-(E)-6,7-Transdihydroxyligustilide |
|
|
|
|
|
|
| Reldesemtiv |
|
|
|
|
|
99.63% |
| REM127 |
|
|
|
|
|
99.18% |
| Rhod-FF tripotassium |
|
|
|
|
|
|
| Ricinelaidic acid |
|
|
|
|
|
|
| Riparin |
|
|
|
|
|
98.00% |
| Ro 18-3981 |
|
|
|
|
|
|
| Ronipamil |
|
|
|
|
|
|
| Rp-8-Br-cGMPS |
|
|
|
|
|
|
| Rp-8-Br-cGMPS sodium |
|
|
|
|
|
99.7% |
| RQ-00311651 |
|
|
|
|
|
|
| RS 30026 |
|
|
|
|
|
|
| RS-5773 |
|
|
|
|
|
|
| RS-93522 |
|
|
|
|
|
|
| Ruthenium red |
|
|
|
|
|
99.95% |
| RWJ 22108 |
|
|
|
|
|
|
| Ryanodine |
|
|
|
|
|
99.91% |
| RyR1-IN-1 |
|
|
|
|
|
|
| RyR2 stabilizer-1 |
|
|
|
|
|
|
| RyRs activator 3 |
|
|
|
|
|
|
| RyRs activator 5 |
|
|
|
|
|
|
| RyRs activator 6 |
|
|
|
|
|
|
| S 16317 |
|
|
|
|
|
|
| S-312 |
|
|
|
|
|
|
| S-312-d |
|
|
|
|
|
|
| S100P-IN-1 |
|
|
|
|
|
99.81% |
| S107 |
|
|
|
|
|
99.77% |
| Sadopine |
|
|
|
|
|
|
| SAK3 |
|
|
|
|
|
99.80% |
| Saquinavir-13C6 |
|
|
|
|
|
|
| Sarafotoxin S6d |
|
|
|
|
|
|
| SAS-0132 |
|
|
|
|
|
|
| SB-237376 |
|
|
|
|
|
|
| SB-237376 free base |
|
|
|
|
|
|
| SCH00013 |
|
|
|
|
|
|
| SCR1693 |
|
|
|
|
|
|
| Selcopintide |
|
|
|
|
|
|
| Selcopintide acetate |
|
|
|
|
|
99.63% |
| Semotiadil |
|
|
|
|
|
|
| Sennoside |
|
|
|
|
|
|
| Ser-Ala-alloresact |
|
|
|
|
|
|
| SERCA2a activator 1 |
|
|
|
|
|
99.71% |
| SERCA2a activator 2 |
|
|
|
|
|
|
| sFTX-3.3 |
|
|
|
|
|
|
| SG-094 |
|
|
|
|
|
97.57% |
| SIM-6080 |
|
|
|
|
|
|
| Sipatrigine |
|
|
|
|
|
99.63% |
| SKF-96365 |
|
|
|
|
|
99.97% |
| SKF-96365 hydrochloride |
|
|
|
|
|
99.93% |
| SL-870495 |
|
|
|
|
|
|
| SM-6586 |
|
|
|
|
|
|
| SNJ-1945 |
|
|
|
|
|
|
| SNX-482 |
|
|
|
|
|
98% |
| SOICR-IN-1 |
|
|
|
|
|
99.62% |
| Sornidipine |
|
|
|
|
|
|
| Spironolactone-d6-1 |
|
|
|
|
|
99.26% |
| SQ 32547 |
|
|
|
|
|
|
| SQ-31765 |
|
|
|
|
|
|
| SR33805 |
|
|
|
|
|
99.78% |
| SR33805 analog |
|
|
|
|
|
|
| SR33805 oxalate |
|
|
|
|
|
|
| Sulcardine |
|
|
|
|
|
|
| Sulcardine hydrochloride |
|
|
|
|
|
|
| Sulcardine sulfate |
|
|
|
|
|
|
| Suloctidil hydrochloride |
|
|
|
|
|
|
| Sulofenur |
|
|
|
|
|
|
| Surlorian |
|
|
|
|
|
99.75% |
| Suvecaltamide |
|
|
|
|
|
99.96% |
| T-Type calcium channel inhibitor 2 |
|
|
|
|
|
|
| TAK-137 |
|
|
|
|
|
|
| Tamolarizine |
|
|
|
|
|
|
| Tamolarizine hydrochloride |
|
|
|
|
|
99.07% |
| TAT-CBD3A6K |
|
|
|
|
|
|
| TAT-CBD3A6K acetate |
|
|
|
|
|
99.76% |
| TAT-EE3 |
|
|
|
|
|
99.89% |
| Taurolithocholic acid |
|
|
|
|
|
98.38% |
| Taurolithocholic acid sodium salt |
|
|
|
|
|
99.81% |
| Taurolithocholic acid-d4 |
|
|
|
|
|
98.36% |
| Taurolithocholic acid-d4 sodium |
|
|
|
|
|
99.4% |
| Taurolithocholic acid-d4-1 sodium |
|
|
|
|
|
|
| Taurolithocholic acid-d5 |
|
|
|
|
|
|
| Taurolithocholic Acid-d5 sodium |
|
|
|
|
|
|
| TDN345 |
|
|
|
|
|
|
| Terflavoxate |
|
|
|
|
|
|
| TGR5 Receptor Agonist |
|
|
|
|
|
99.67% |
| Thio-NADP |
|
|
|
|
|
96.57% |
| TMB-8 |
|
|
|
|
|
98.0% |
| TMDJ-035 |
|
|
|
|
|
99.92% |
| TPC2-A1-N |
|
|
|
|
|
99.86% |
| trans-AzoTAB |
|
|
|
|
|
|
| trans-Ned 19 |
|
|
|
|
|
99.33% |
| Trepibutone |
|
|
|
|
|
99.83% |
| Triphenylethylene |
|
|
|
|
|
99.86% |
| Trombodipine |
|
|
|
|
|
|
| Troponin modulator 1 |
|
|
|
|
|
|
| TROX-1 |
|
|
|
|
|
99.55% |
| TSLP modulator-1 |
|
|
|
|
|
99.61% |
| TTA-A2 |
|
|
|
|
|
99.33% |
| TTA-A8 |
|
|
|
|
|
|
| TTA-P1 |
|
|
|
|
|
|
| TTA-P2 |
|
|
|
|
|
99.58% |
| TTA-Q6 |
|
|
|
|
|
99.97% |
| TTA-Q6(isomer) |
|
|
|
|
|
99.91% |
| U 92032 |
|
|
|
|
|
|
| UK 52831 |
|
|
|
|
|
|
| UK 55444 |
|
|
|
|
|
|
| UK-59811 hydrochloride |
|
|
|
|
|
|
| UK51656 |
|
|
|
|
|
|
| Ulixacaltamide |
|
|
|
|
|
99.26% |
| Ulixacaltamide-d9 hydrochloride |
|
|
|
|
|
|
| UR 8225 |
|
|
|
|
|
|
| Vatanidipine |
|
|
|
|
|
|
| Vatanidipine hydrochloride |
|
|
|
|
|
|
| Verapamil-d7 |
|
|
|
|
|
|
| Verticilide |
|
|
|
|
|
|
| VHB937 |
|
|
|
|
|
99.65% |
| VK-II-36 |
|
|
|
|
|
99.62% |
| VU0606170 |
|
|
|
|
|
|
| VU6032735 |
|
|
|
|
|
99.26% |
| w-Conotoxin SVIB |
|
|
|
|
|
|
| WIN-64821 |
|
|
|
|
|
|
| WMS-1410 |
|
|
|
|
|
|
| wt hMLN |
|
|
|
|
|
|
| wt hMLN TFA |
|
|
|
|
|
95.0% |
| WU-07047 |
|
|
|
|
|
|
| Wy 27569 |
|
|
|
|
|
|
| XAT-13 |
|
|
|
|
|
|
| XAT-14 |
|
|
|
|
|
|
| Xestospongin C |
|
|
|
|
|
99.9% |
| Yangambin |
|
|
|
|
|
98.27% |
| YM-344484 |
|
|
|
|
|
|
| YM-430 |
|
|
|
|
|
|
| YMRF-NH2 |
|
|
|
|
|
|
| Yoda2 |
|
|
|
|
|
99.57% |
| YS 035 hydrochloride |
|
|
|
|
|
99.15% |
| YS-201 |
|
|
|
|
|
99.70% |
| ZSET1446 |
|
|
|
|
|
98.33% |
| α-Conotoxin PeIA |
|
|
|
|
|
|
| α-L-Rhamnose monohydrate |
|
|
|
|
|
98.0% |
| α-Obscurine derivative-1 |
|
|
|
|
|
|
| α2δ ligand 1 |
|
|
|
|
|
|
| β-Amino Acid Imagabalin Hydrochloride |
|
|
|
|
|
|
| γ-Glutamylserine |
|
|
|
|
|
99.95% |
| γ-Glutamylserine TFA |
|
|
|
|
|
|
| ω-Agatoxin IVA |
|
|
|
|
|
98.71% |
| ω-Agatoxin IVA TFA |
|
|
|
|
|
99.52% |
| ω-Agatoxin TK |
|
|
|
|
|
99% |
| ω-Conotoxin Bu8 |
|
|
|
|
|
|
| ω-Conotoxin CnVIIA |
|
|
|
|
|
|
| ω-Conotoxin CVIA |
|
|
|
|
|
|
| ω-Conotoxin CVID |
|
|
|
|
|
|
| ω-Conotoxin CVIE |
|
|
|
|
|
|
| ω-Conotoxin CVIF |
|
|
|
|
|
|
| ω-Conotoxin FVIA |
|
|
|
|
|
|
| ω-Conotoxin GVIA |
|
|
|
|
|
|
| ω-conotoxin MoVIA |
|
|
|
|
|
|
| ω-Conotoxin MVIID |
|
|
|
|
|
|
| ω-Conotoxin SO3 |
|
|
|
|
|
|
| ω-Grammotoxin SIA |
|
|
|
|
|
|
| ω-Hexatoxin-Hv1a |
|
|
|
|
|
|
| ω-Hexatoxin-Hv1a TFA |
|
|
|
|
|
97.49% |
| ω-Tbo-IT1 |
|
|
|
|
|
|
| ω-Conotoxin GVIA TFA |
|
|
|
|
|
98.64% |
| ω-Conotoxin MVIIC |
|
|
|
|
|
|
| ω-Conotoxin MVIIC TFA |
|
|
|
|
|
99.43% |
| Tetracaine |
|
|
|
|
|
99.87% |
| Clevidipine-15N,d10 |
|
|
|
|
|
|
| Clevidipine-d7 |
|
|
|
|
|
|
| Clevidipine |
|
|
|
|
|
99.59% |
| Syringaresinol |
|
|
|
|
|
99.66% |
| Magnesium sulfate heptahydrate, meets analytical specification of Ph. Eur. BP USP FCC |
|
|
|
|
|
|
| Magnesium sulfate heptahydrate, United States Pharmacopeia (USP) Reference Standard |
|
|
|
|
|
|
| Notoginsenoside Ft1 |
|
|
|
|
|
99.49% |
| Tris(2-chloroethyl) phosphate |
|
|
|
|
|
97.07% |
| Tris(2-chloroethyl)phosphate-d12 |
|
|
|
|
|
99.15% |
| Trimethadione |
|
|
|
|
|
99.59% |
| Dantrolene sodium hemiheptahydrate |
|
|
|
|
|
99.79% |
| Dantrolene |
|
|
|
|
|
99.93% |
| Lercanidipine |
|
|
|
|
|
99.93% |
| Lercanidipine-d3 hydrochloride |
|
|
|
|
|
98.14% |
| Etiracetam-d3 |
|
|
|
|
|
|
| Ethosuximide-d3 |
|
|
|
|
|
|
| Ethosuximide-13C, d3 |
|
|
|
|
|
|
| Ethosuximide-d5 |
|
|
|
|
|
|
| Ethosuximide |
|
|
|
|
|
99.35% |
| Dihydrocytochalasin B |
|
|
|
|
|
99.0% |
| Penfluridol |
|
|
|
|
|
99.84% |
| Ginsenoside Rd |
|
|
|
|
|
99.88% |
| Ginsenoside Rd (Standard) |
|
|
|
|
|
|
| Ginsenoside Rf |
|
|
|
|
|
99.48% |
| Ginsenoside Ro |
|
|
|
|
|
99.81% |
| Tazanolast |
|
|
|
|
|
99.50% |
| Iganidipine |
|
|
|
|
|
|
| Isradipine |
|
|
|
|
|
99.97% |
| Isradipine-d3 |
|
|
|
|
|
|
| Isradipine-d6 |
|
|
|
|
|
|
| Isradipine-d7 |
|
|
|
|
|
|
| Ethacrynic acid |
|
|
|
|
|
99.90% |
| Ethacrynic acid sodium |
|
|
|
|
|
|
| Ebselen |
|
|
|
|
|
99.80% |
| Efonidipine |
|
|
|
|
|
99.88% |
| Magnesium chloride hexahydrate, for molecular biology |
|
|
|
|
|
99.40% |
| Magnesium chloride hexahydrate, for cell culture |
|
|
|
|
|
|
| Argireline |
|
|
|
|
|
99.86% |
| Dronedarone-d6 hydrochloride |
|
|
|
|
|
|
| Dronedarone |
|
|
|
|
|
99.93% |
| Riodipine |
|
|
|
|
|
|
| Gabapentin-d4 |
|
|
|
|
|
99.44% |
| Gabapentin-d10 |
|
|
|
|
|
|
| Gabapentin |
|
|
|
|
|
99.99% |
| Gabapentin enacarbil |
|
|
|
|
|
99.90% |
| Gabapentin hydrochloride |
|
|
|
|
|
98.0% |
| Gabapentin-d4 hydrochloride |
|
|
|
|
|
|
| Gabapentin-d6 hydrochloride |
|
|
|
|
|
|
| A-425619 |
|
|
|
|
|
99.96% |
| Pinaverium bromide |
|
|
|
|
|
99.73% |
| Pinaverium bromide-d4 |
|
|
|
|
|
|
| Pinaverium bromide-d4-1 |
|
|
|
|
|
|
| Cavidine |
|
|
|
|
|
|
| Carbamazepine |
|
|
|
|
|
99.90% |
| Norverapamil |
|
|
|
|
|
|
| Demethylsuberosin |
|
|
|
|
|
99.71% |
| Bifemelane |
|
|
|
|
|
|
| Diacerein |
|
|
|
|
|
98.64% |
| Semotiadil recemate fumarate |
|
|
|
|
|
|
| Xanthone |
|
|
|
|
|
99.97% |
| Zonisamide-d4 |
|
|
|
|
|
99.11% |
| Phytolaccagenin |
|
|
|
|
|
99.86% |
| Tiapamil hydrochloride |
|
|
|
|
|
|
| Tiaramide |
|
|
|
|
|
|
| Devapamil |
|
|
|
|
|
99.63% |
| Diltiazem |
|
|
|
|
|
99.70% |
| Diltiazem-d4 |
|
|
|
|
|
|
| Diltiazem-d6 |
|
|
|
|
|
|
| Diltiazem malate |
|
|
|
|
|
|
| Digitoxin |
|
|
|
|
|
99.18% |
| Dopropidil |
|
|
|
|
|
|
| Nexopamil racemate |
|
|
|
|
|
|
| Nesiritide |
|
|
|
|
|
99.75% |
| Nefiracetam |
|
|
|
|
|
99.87% |
| Nefiracetam (Standard) |
|
|
|
|
|
98% |
| Progesterone/BSA |
|
|
|
|
|
|
| Amlodipine-d4 |
|
|
|
|
|
98.46% |
| Amlodipine |
|
|
|
|
|
99.87% |
| Ibutilide-d5 fumarate |
|
|
|
|
|
|
| Butamben-d9 |
|
|
|
|
|
|
| Butamben |
|
|
|
|
|
99.82% |
| Nilvadipine |
|
|
|
|
|
99.66% |
| Nilvadipine-d4 |
|
|
|
|
|
|
| Nicardipine |
|
|
|
|
|
99.75% |
| Nisoldipine |
|
|
|
|
|
99.56% |
| Nisoldipine-d4 |
|
|
|
|
|
|
| Nisoldipine-d6 |
|
|
|
|
|
|
| Nisoldipine-d7 |
|
|
|
|
|
|
| Nisoldipine-d3 |
|
|
|
|
|
|
| Dehydronitrosonisoldipine |
|
|
|
|
|
98.86% |
| Nitrendipine |
|
|
|
|
|
99.71% |
| Nitrendipine-d5 |
|
|
|
|
|
99.77% |
| Nimodipine-d7 |
|
|
|
|
|
99.35% |
| Nimodipine |
|
|
|
|
|
99.86% |
| Urolithin C |
|
|
|
|
|
98.0% |
| Levemopamil |
|
|
|
|
|
|
| Levosemotiadil |
|
|
|
|
|
|
| Levamlodipine |
|
|
|
|
|
98.06% |
| Levamlodipine-d4 |
|
|
|
|
|
99.74% |
| Levomepromazine |
|
|
|
|
|
99.94% |
| Levomepromazine maleate |
|
|
|
|
|
99.92% |
| Barnidipine |
|
|
|
|
|
|
| Bupivacaine |
|
|
|
|
|
99.95% |
| Bupivacaine-d9 |
|
|
|
|
|
99.04% |
| Bupivacaine hydrochloride monohydrate |
|
|
|
|
|
|
| Palonidipine |
|
|
|
|
|
|
| Halofuginone |
|
|
|
|
|
99.28% |
| Halofuginone hydrobromide |
|
|
|
|
|
99.85% |
| Pincainide |
|
|
|
|
|
|
| Heteroclitin D |
|
|
|
|
|
99.91% |
| Isosorbide |
|
|
|
|
|
98.76% |
| Isosinensetin |
|
|
|
|
|
99.90% |
| Glutarimide |
|
|
|
|
|
98.0% |
| Topiramate |
|
|
|
|
|
99.76% |
| Topiramate-13C |
|
|
|
|
|
|
| Topiramate-13C6 |
|
|
|
|
|
|
| Topiramate-13C6-1 |
|
|
|
|
|
|
| Topiramate D12 |
|
|
|
|
|
|
| Topiramate lithium |
|
|
|
|
|
|
| Ascorbyl palmitate |
|
|
|
|
|
99.62% |
| Lacidipine-d10 |
|
|
|
|
|
|
| Lacidipine-13C4 |
|
|
|
|
|
|
| Lacidipine-13C8 |
|
|
|
|
|
|
| Lacidipine |
|
|
|
|
|
99.40% |
| Prenylamine |
|
|
|
|
|
99.14% |
| Troxipide |
|
|
|
|
|
99.62% |
| Trimebutine |
|
|
|
|
|
99.42% |
| Trimebutine (Standard) |
|
|
|
|
|
98% |
| Trimebutine-d5 fumarate |
|
|
|
|
|
|
| Trimebutine-d3 hydrochloride |
|
|
|
|
|
|
| Tilmicosin |
|
|
|
|
|
98.0% |
| Teludipine-d6 |
|
|
|
|
|
|
| Teludipine hydrochloride |
|
|
|
|
|
|
| Lemildipine |
|
|
|
|
|
99.58% |
| Calcium citrate tetrahydrate, 99% |
|
|
|
|
|
99.65% |
| Cinnarizine-d8 |
|
|
|
|
|
98.24% |
| Cinnarizine |
|
|
|
|
|
99.56% |
| Cinepazide |
|
|
|
|
|
|
| Palmitoylglycine |
|
|
|
|
|
99.84% |
| Palmitoylglycine-d31 |
|
|
|
|
|
99.40% |
| Anisodine |
|
|
|
|
|
|
| Anisodine hydrobromide |
|
|
|
|
|
|
| Hypaconitine |
|
|
|
|
|
99.49% |
| 1-Octanol-d17 |
|
|
|
|
|
99.09% |
| 1-Octanol-d2-1 |
|
|
|
|
|
|
| 1-Octanol-d2 |
|
|
|
|
|
99.0% |
| 1-Octanol-d5 |
|
|
|
|
|
|
| 1-Octanol |
|
|
|
|
|
98.0% |
| Thapsigargin |
|
|
|
|
|
99.87% |
| Picolinafen |
|
|
|
|
|
|
| Flufenamic acid-13C6 |
|
|
|
|
|
99.5% |
| Flufenamic acid-d4 |
|
|
|
|
|
|
| Flufenamic acid |
|
|
|
|
|
99.93% |
| Flubendiamide |
|
|
|
|
|
99.42% |
| Amlodipine-1,1,2,2-d4 maleate |
|
|
|
|
|
98.04% |
| Amlodipine hydrochloride |
|
|
|
|
|
|
| Acetylcholine chloride |
|
|
|
|
|
99.91% |
| Acetylcholine-d4 chloride |
|
|
|
|
|
98.0% |
| Acetylcholine-d9 chloride |
|
|
|
|
|
98.47% |
| Potassium chloride, for cell culture |
|
|
|
|
|
99.80% |
| Cypermethrin |
|
|
|
|
|
99.93% |
| (R)-Clevidipine-13C,d3 |
|
|
|
|
|
|
| Tetrandrine |
|
|
|
|
|
99.90% |
| Saquinavir-d9 |
|
|
|
|
|
|
| Saquinavir |
|
|
|
|
|
99.77% |
| Saquinavir mesylate |
|
|
|
|
|
99.40% |
| Fasudil |
|
|
|
|
|
99.98% |
| Lomerizine |
|
|
|
|
|
|
| Glaucine |
|
|
|
|
|
99.55% |
| Acetylcholine-d13 bromide |
|
|
|
|
|
98.55% |
| Acetylcholine-d16 bromide |
|
|
|
|
|
98.0% |
| Acetylcholine-d4 bromide |
|
|
|
|
|
98.0% |
| Acetylcholine-d9 bromide |
|
|
|
|
|
98.47% |
| Deltamethrin |
|
|
|
|
|
99.96% |
| Brompheniramine |
|
|
|
|
|
99.82% |
| Yunaconitine |
|
|
|
|
|
99.47% |
| Breviscapine |
|
|
|
|
|
99.13% |
| Terodiline |
|
|
|
|
|
|
| Cyclopiazonic acid |
|
|
|
|
|
99.86% |
| Cyclandelate |
|
|
|
|
|
98.66% |
| Cyclic ADP-ribose |
|
|
|
|
|
95% |
| Polygalasaponin F |
|
|
|
|
|
99.85% |
| Formic acid ammonium |
|
|
|
|
|
98.47% |
| Formic acid-d5 ammonium |
|
|
|
|
|
|
| Praeruptorin C |
|
|
|
|
|
99.78% |
| Praeruptorin A |
|
|
|
|
|
99.57% |
| Praeruptorin E |
|
|
|
|
|
99.18% |
| Econazole |
|
|
|
|
|
99.93% |
| Econazole-d6 |
|
|
|
|
|
|
| Tetracaine hydrochloride |
|
|
|
|
|
99.91% |
| Propiverine hydrochloride |
|
|
|
|
|
99.80% |
| Propiverine-d7 hydrochloride |
|
|
|
|
|
|
| Lercanidipine-13C,d3 hydrochloride |
|
|
|
|
|
|
| Lercanidipine-13C,d3-1 hydrochloride |
|
|
|
|
|
|
| Lercanidipine hydrochloride |
|
|
|
|
|
99.93% |
| Efonidipine hydrochloride |
|
|
|
|
|
|
| Efonidipine hydrochloride monoethanolate |
|
|
|
|
|
99.28% |
| Efonidipine hydrochloride monoethanolate (Standard) |
|
|
|
|
|
98% |
| Landiolol hydrochloride |
|
|
|
|
|
99.82% |
| Landiolol hydrochloride (Standard) |
|
|
|
|
|
|
| Norverapamil-d6 hydrochloride |
|
|
|
|
|
|
| Diltiazem-d3 hydrochloride |
|
|
|
|
|
98.70% |
| Diltiazem-(acetoxy-d3) hydrochloride |
|
|
|
|
|
|
| Diltiazem hydrochloride (Standard) |
|
|
|
|
|
98% |
| Diltiazem-d4-1 hydrochloride |
|
|
|
|
|
|
| Diltiazem-d5 hydrochloride |
|
|
|
|
|
|
| Diltiazem hydrochloride |
|
|
|
|
|
99.47% |
| Dopropidil hydrochloride |
|
|
|
|
|
|
| Nicardipine hydrochloride |
|
|
|
|
|
99.73% |
| Nicardipine-d3 hydrochloride |
|
|
|
|
|
99.56% |
| Nicardipine-13C,d3 hydrochloride |
|
|
|
|
|
|
| Nicardipine-d4 hydrochloride |
|
|
|
|
|
|
| Levobunolol hydrochloride |
|
|
|
|
|
99.95% |
| Barnidipine hydrochloride |
|
|
|
|
|
99.94% |
| Barnidipine hydrochloride (Standard) |
|
|
|
|
|
|
| Barnidipine-d5 hydrochloride |
|
|
|
|
|
98.0% |
| Bupivacaine hydrochloride |
|
|
|
|
|
99.85% |
| Flunarizine dihydrochloride |
|
|
|
|
|
99.90% |
| Flunarizine-d8 dihydrochloride |
|
|
|
|
|
|
| Fasudil Hydrochloride |
|
|
|
|
|
99.97% |
| Fasudil hydrochloride semihydrate |
|
|
|
|
|
|
| Lomerizine dihydrochloride |
|
|
|
|
|
99.95% |
| Terodiline hydrochloride |
|
|
|
|
|
99.5% |
| Minocycline hydrochloride |
|
|
|
|
|
99.71% |
| Mibefradil dihydrochloride |
|
|
|
|
|
99.71% |
| Verapamil-d3 hydrochloride |
|
|
|
|
|
96.13% |
| Verapamil hydrochloride |
|
|
|
|
|
99.98% |
| (R)-Verapamil hydrochloride |
|
|
|
|
|
99.37% |
| Manidipine dihydrochloride |
|
|
|
|
|
99.84% |
| Fendiline hydrochloride |
|
|
|
|
|
99.78% |
| Benidipine hydrochloride |
|
|
|
|
|
99.80% |
| Aprindine hydrochloride |
|
|
|
|
|
98.96% |
| Ranolazine dihydrochloride |
|
|
|
|
|
99.99% |
| Ranolazine-d8 dihydrochloride |
|
|
|
|
|
99.0% |
| Flavoxate hydrochloride |
|
|
|
|
|
99.70% |
| Flavoxate-d4 hydrochloride |
|
|
|
|
|
|
| Dipeptide 2 |
|
|
|
|
|
98.12% |
| Dantrolene sodium |
|
|
|
|
|
99.79% |
| Nifedipine-d4 |
|
|
|
|
|
|
| Nifedipine-d6 |
|
|
|
|
|
|
| Nifedipine-13C8 |
|
|
|
|
|
|
| Nifedipine |
|
|
|
|
|
98.91% |
| Magnesium sulfate |
|
|
|
|
|
99.03% |
| Magnesium sulfate, for cell culture |
|
|
|
|
|
99.0% |
| Catharanthine Sulfate |
|
|
|
|
|
|
| Ionomycin |
|
|
|
|
|
99.27% |
| Ionomycin calcium |
|
|
|
|
|
98.32% |
| Mioflazine |
|
|
|
|
|
|
| Minocycline-d7 |
|
|
|
|
|
|
| Mibefradil |
|
|
|
|
|
|
| Monascorubrin |
|
|
|
|
|
98.0% |
| Verapamil |
|
|
|
|
|
99.88% |
| Verapamil-d3 |
|
|
|
|
|
|
| Verapamil EP Impurity C hydrochloride |
|
|
|
|
|
99.61% |
| Norverapamil hydrochloride |
|
|
|
|
|
99.80% |
| Carboxyatractyloside tripotassium |
|
|
|
|
|
99.97% |
| Myomodulin |
|
|
|
|
|
|
| D-myo-Inositol-1,3,4,5-tetraphosphate sodium |
|
|
|
|
|
98.24% |
| Isotachysterol 3 |
|
|
|
|
|
|
| Pulegone-d8 |
|
|
|
|
|
|
| Pulegone |
|
|
|
|
|
99.57% |
| Coelenterazine h |
|
|
|
|
|
99.41% |
| Suloctidil |
|
|
|
|
|
99.9% |
| Ifenprodil |
|
|
|
|
|
99.94% |
| Fendiline |
|
|
|
|
|
99.41% |
| Bepridil |
|
|
|
|
|
99.93% |
| Bepridil hydrochloride |
|
|
|
|
|
99.98% |
| Bepridil-d5 hydrochloride |
|
|
|
|
|
|
| Bepridil hydrochloride hydrate |
|
|
|
|
|
99.86% |
| Benzocaine hydrochloride |
|
|
|
|
|
99.83% |
| Levamlodipine besylate Hemipentahydrate |
|
|
|
|
|
|
| Levamlodipine besylate |
|
|
|
|
|
99.84% |
| Amlodipine besylate |
|
|
|
|
|
99.72% |
| Amlodipine-d4 besylate |
|
|
|
|
|
|
| Agaric acid |
|
|
|
|
|
99.45% |
| Paxilline |
|
|
|
|
|
99.91% |
| Spironolactone-d7 |
|
|
|
|
|
99.96% |
| Spironolactone |
|
|
|
|
|
99.81% |
| Cilnidipine |
|
|
|
|
|
99.89% |
| Cilnidipine-d4 |
|
|
|
|
|
|
| Cilnidipine-d7 |
|
|
|
|
|
|
| Sitamaquine |
|
|
|
|
|
|
| Bevantolol hydrochloride |
|
|
|
|
|
98.98% |
| Bevantolol-d7 hydrochloride |
|
|
|
|
|
|
| Hyperforin |
|
|
|
|
|
|
| Hyperforin dicyclohexylammonium salt |
|
|
|
|
|
99.48% |
| Cycleanine |
|
|
|
|
|
99.80% |
| Cinchonine |
|
|
|
|
|
99.71% |
| Darodipine |
|
|
|
|
|
|
| Ifenprodil tartrate |
|
|
|
|
|
99.94% |
| Catharanthine Tartrate |
|
|
|
|
|
98.88% |
| Argireline acetate |
|
|
|
|
|
|
| Ziconotide acetate |
|
|
|
|
|
99.17% |
| Katacalcin |
|
|
|
|
|
98.29% |
| Calcium ionophore I |
|
|
|
|
|
99.6% |
| Calpain-1, Human Erythrocyte |
|
|
|
|
|
|
| Catharanthine |
|
|
|
|
|
99.46% |
| Rhodojaponin VI |
|
|
|
|
|
|
| Albanin A |
|
|
|
|
|
97.67% |
| Anipamil |
|
|
|
|
|
99.34% |
| Azelnidipine |
|
|
|
|
|
99.79% |
| Azelnidipine-d7 |
|
|
|
|
|
|
| Azumolene |
|
|
|
|
|
99.11% |
| Aranidipine |
|
|
|
|
|
99.12% |
| Azimilide |
|
|
|
|
|
99.01% |
| Azimilide dihydrochloride |
|
|
|
|
|
98.17% |
| Azimilide-d8 dihydrochloride |
|
|
|
|
|
|
| Wilforgine |
|
|
|
|
|
99.67% |
| Ranolazine |
|
|
|
|
|
99.57% |
| Ranolazine-d3 |
|
|
|
|
|
99.49% |
| Ranolazine-d5 |
|
|
|
|
|
|
| Ranolazine-d8 |
|
|
|
|
|
99.83% |
| Felodipine |
|
|
|
|
|
99.83% |
| Felodipine-d3 |
|
|
|
|
|
99.78% |
| Felodipine-d5 |
|
|
|
|
|
|
| Fenoverine-d8 |
|
|
|
|
|
98.88% |
| Fenoverine |
|
|
|
|
|
99.69% |
| Typhaneoside |
|
|
|
|
|
99.74% |
| Manidipine-d4 |
|
|
|
|
|
|
| Manidipine |
|
|
|
|
|
99.92% |
| Trimebutine maleate |
|
|
|
|
|
99.66% |
| Trimebutine maleate (Standard) |
|
|
|
|
|
98% |
| Cinepazide Maleate |
|
|
|
|
|
99.74% |
| Amlodipine-d4 maleate |
|
|
|
|
|
|
| Amlodipine-d9 maleate |
|
|
|
|
|
|
| Amlodipine maleate |
|
|
|
|
|
99.87% |
| Brompheniramine maleate |
|
|
|
|
|
99.93% |
| β-Cyfluthrin |
|
|
|
|
|
99.94% |
| Ophiopogonin D |
|
|
|
|
|
99.80% |
| Norbormide |
|
|
|
|
|
98.91% |
| Ziconotide |
|
|
|
|
|
|
| Ziconotide TFA |
|
|
|
|
|
|